Medical materials

Publication
  • WFH •
  • 20 April, 2026 •
  • •

Physical Activity and Bleed Prevention for People With Severe Haemophilia A Treated With Once-Weekly Efanesoctocog Alfa: A Plain-Language Summary of 12-Month Interim Results From the FREEDOM Study

Ana Boban, Kate Talks, Irena Preložnik Zupan, Paul Van der Valk, Josefin Blomkvist, Elena Santagostino, Markus Fusser, Jan Astermark

Publication
  • WFH •
  • 20 April, 2026 •
  • •

Joint Health Outcomes with Efanesoctocog Alfa in Adults/Adolescents from XTEND-1 Continuing in XTEND-ed: Plain Language Summary

Christoph Königs, Annette von Drygalski, Cedric Hermans, Barbara A. Konkle, Paul Van der Valk, Liane Khoo, Nobuaki Suzuki, Liqi Feng, Umer Khan, Linda Bystrická, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Robert Klamroth

Publication
  • WFH •
  • 20 April, 2026 •
  • •

Hemophilia Life Stages and Changes Global Survey of People with Hemophilia, Caregivers, and Hematologists: Patient Experience According to Disease Severity and Gender

Mark W. Skinner, Kim Isenberg, Maria Elisa Mancuso, Stacy E. Croteau, Jacose Bell, Pamela Wilton, Michael Recht, Lynn Malec

Publication
  • WFH •
  • 20 April, 2026 •
  • •

Plain Language Summary: What is Extravascular Distribution of Factor IX and how does it Affect Management of Those with Haemophilia B?

Cedric Hermans, Carmen Escuriola Ettingshausen, Michael Laffan, Davide Matino, Niamh O’Connell, Robert Sidonio, Rolf Ljung

Sign up for alerts